Health

Transvenous phrenic nerve stimulation (TPNS) has been identified as a potential treatment option for patients with central sleep apnea and heart failure. Upon analysis of the Remedē system pivotal trial, it was discovered that the use of TPNS resulted in a significantly higher chance of improved clinical outcomes for these patients. This article aims to
0 Comments
Insomnia has long been associated with a myriad of health issues, but a recent 5-year longitudinal study conducted in Canada has shed light on the significant connection between insomnia and depression. The study, presented at the annual SLEEP meeting, revealed that individuals with insomnia are at a greater risk of developing depression over time. This
0 Comments
Dozens of passengers who recently returned from an international cruise experienced an unknown illness while on a flight to Houston. This incident highlights the potential health risks associated with international travel, especially in the midst of a global pandemic. Dr. Anthony Fauci, a prominent figure in the country’s COVID response, is set to testify before
0 Comments
Chronic inflammatory demyelinating polyneuropathy (CIDP) is a complex disease that often goes undiagnosed or misdiagnosed due to its rarity and heterogeneity. Current standard treatments like intravenous immunoglobulin (IVIG), steroids, and plasma exchange have limitations in some CIDP phenotypes, making the need for valid biomarkers crucial. Dr. Jeffrey Allen of the University of Minnesota highlights the
0 Comments
The recent warning issued by the FDA to Akan Biosciences, the maker of an allogenic, adipose-derived stromal vascular fraction (SVF) product, sheds light on the regulatory challenges faced by companies in the field of regenerative medicine. This article aims to analyze the FDA’s warning to Akan Biosciences and explore the implications for the broader regenerative
0 Comments